Reducing occurrence and severity of pneumonia due to pandemic H1N1 2009 by early Oseltamivir administration: A retrospective study in Mexico

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Higuera Iglesias, Anjarath Lorena ^a   Kudo, Koichiro ^b   Manabe, Toshie ^b   Corcho Berdugo, Alexander Enrique ^a   Corrales Baeza, Ariel ^a   Alfaro Ramos, Leticia ^a   Guevara Gutiérrez, René ^a   Manjarrez Zavala, María Eugenia ^a   Takasaki, Jin ^b   Izumi, Shinyu ^b   Bautista, Edgar ^a   Perez Padilla, José Rogelio ^a  

^a National Institute of Respiratory Diseases   (Mexico)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

OSELTAMIVIR;

2009 H1N1 INFLUENZA; ADOLESCENT; ADULT; AGED; ANTIVIRAL THERAPY; ARTICLE; ARTIFICIAL VENTILATION; CHILD; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; EARLY INTERVENTION; FEMALE; HOSPITAL DISCHARGE; HUMAN; INFANT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEXICO; ONSET AGE; OUTCOME ASSESSMENT; PANDEMIC; RETROSPECTIVE STUDY; VIRUS PNEUMONIA;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MEXICO; MIDDLE AGED; MULTIVARIATE ANALYSIS; OSELTAMIVIR; PANDEMICS; PATIENT ADMISSION; PATIENT DISCHARGE; PNEUMONIA, VIRAL; PROBABILITY; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 80054032813     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021838     Document Type: Article

References (20)

1. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, Hernandez M, Quiñones-Falconi F, et al. (2009) Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 361: 680-689.
2. World Health Organization (2010) Pandemic (H1N1) 2009 - update 94. Available: http://www.who.int/csr/don/2010_4_23a/en/index.html. Accessed 2010 April 24.
3. Bautista E, Chotpitayasunondh T, Gao Z, Harper SA, Shaw M, et al. Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza (2010) Clinical aspects of Pandemic 2009 Influenza A (H1N1) virus infection. N Engl J Med 362: 1708-1719.
4. SALUDE (2010) Situación actual de la epidemia. Available: http://portal.salud.gob.mx/contenidos/noticias/influenza/estadisticas.html. Accessed 2010 September 1. (In Spanish.).
5. World Health Organization (2010) WHO guidelines for pharmacological management of pandemic (H1N1) 2009 influenza and other influenza viruses. Available: http://www.who.int/csr/resources/publications/swineflu/h1n1_guidelines_pharmaceutical_mngt.pdf. Accessed 2010 September 1.
6. Centers for Disease Control and Prevention (2010) Updated interim recommendations for the use of antiviral medications in the treatment and prevention of influenza for the 2009-2010 season. Available: http://www.cdc.gov/h1n1flu/recommendations.htm. Accessed 2010 July 29.
7. Webb SA, Pettilä V, Seppelt I, Bellomo R, Bailey M, et al. The ANZIC Influenza Investigators (2009) Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med 361: 1925-1934.
8. Louie JK, Acosta M, Winter K, Jean C, Gavali S, et al. (2009) Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA 302: 1896-1902.
9. Kumar A, Zarychanski R, Pinto R, Cook DJ, Marshall J, et al. (2009) Critically ill patients with 2009 influenza A (H1N1) infection in Canada. JAMA 302: 1872-1879.
10. Roche Laboratories, Inc. (2010) Tamiflu product information. Prescribing information document from Roche. Last updated September 2010. Available: http://www.gene.com/gene/products/information/tamiflu/pdf/pi.pdf) Accessed 2010 December 3.
11. Agresti Alan, (2010) Analysis of Ordinal Categorical Data, 2nd Edition. April 2010, Wiley.
12. Domínguez-Cherit G, Lapinsky SE, Macias AE, Pinto R, Espinosa-Perez L, et al. (2009) Critically ill patients with 2009 influenza A(H1N1) in Mexico. JAMA 302: 1880-1887.
13. Shieh WJ, Blau DM, Denison AM, Deleon-Carnes M, Adem P, et al. (2010) 2009 pandemic influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States. Am J Pathol 177: 166-175.
14. Centers for Disease Control and Prevention (2010) Patients hospitalized with 2009 pandemic influenza A (H1N1) - New York City, May 2009. MMWR Morb Mortal Wkly Rep 58: 1436-1440.
15. Lee N, Choi KW, Chan PK, Hui DS, Lui GC, et al. (2010) Outcomes of adults hospitalised with severe influenza. Thorax 65: 510-515.
16. Matrosovich MN, Matrosovich TY, Gray T, Roberts NA, Klenk HD, (2004) Neuraminidase is important for the initiation of influenza virus infection of human airway epithelium. J Virol 78: 12665-12667.
17. Su B, Wurtzer S, Rameix-Welti MA, Dwyer D, van der Werf S, et al. (2009) Enhancement of the influenza A hemagglutinin (HA)-mediated cell-cell fusion and virus entry by the viral neuraminidase. PLoS One 4: e8495.
18. Hayden FG, Fritz R, Lobo MC, Alvord W, Strober W, et al. (1998) Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J Clin Invest 101: 643-649.
19. Safronetz D, Rockx B, Feldmann F, Belisle SE, Palermo RE, et al. (2010) Pandemic swine-origin H1N1 influenza A virus isolates show heterogeneous virulence in macaques. J Virol doi:. 10.1128/JVI.01848-10. (Online published ahead of print.) Accessed 2011 January 8.
20. To KK, Hunh IF, Li IW, Lee K-L, Koo C-K, et al. (2010) Delayed clearance of viral load and marked cytokine action in severe cases of pandemic H1N1 2009 influenza virus infection. Clin Infect Dis 50: 850-9.